SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950133-01-000008
Filing Date
2001-01-02
Accepted
2001-01-02 00:00:00
Documents
5
Period of Report
2000-12-19
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT w43971e8-k.txt 8-K 2933
2 PRESS RELEASE w43971ex99-1.txt EX-99.1 6389
3 FORM OF NOTE PURCHASE AGREEMENT w43971ex99-2.txt EX-99.2 99894
4 CONVERTIBLE NOTE w43971ex99-3.txt EX-99.3 29259
5 FORM OF INVESTOR RIGHTS AGREEMENT w43971ex99-4.txt EX-99.4 85532
  Complete submission text file 0000950133-01-000008.txt   226040
Mailing Address 8320 GUILFORD ROAD SUITE C 12111 PARKLAWN DR COLUMBIA MD 21046
Business Address 8320 GUILFORD RD STE C COLUMBIA MD 21046 3078543900
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26770 | Film No.: 1500333
SIC: 2836 Biological Products, (No Diagnostic Substances)